BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 8599254)

  • 1. p53 protein overexpression in astrocytic neoplasms.
    Cho MY; Jung SH; Kim TS
    Yonsei Med J; 1995 Dec; 36(6):521-6. PubMed ID: 8599254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical pattern of P53 protein in human astrocytic tumors.
    Howng SL; Hwang SL; Chai CY; Lin HJ
    Kaohsiung J Med Sci; 1996 May; 12(5):279-84. PubMed ID: 8676433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apoptosis and proliferation: correlation with p53 in astrocytic tumours.
    Sarkar C; Karak AK; Nath N; Sharma MC; Mahapatra AK; Chattopadhyay P; Sinha S
    J Neurooncol; 2005 Jun; 73(2):93-100. PubMed ID: 15981097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical detection of p53 protein expression in various childhood astrocytoma subtypes: significance in tumor progression.
    Bodey B; Gröger AM; Bodey B; Siegel SE; Kaiser HE
    Anticancer Res; 1997; 17(2A):1187-94. PubMed ID: 9137469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of p53 immunohistochemistry in differentiating reactive gliosis from malignant astrocytic lesions.
    Yaziji H; Massarani-Wafai R; Gujrati M; Kuhns JG; Martin AW; Parker JC
    Am J Surg Pathol; 1996 Sep; 20(9):1086-90. PubMed ID: 8764745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of the p53 protein in a spectrum of astrocytic tumours.
    Ellison DW; Gatter KC; Steart PV; Lane DP; Weller RO
    J Pathol; 1992 Dec; 168(4):383-6. PubMed ID: 1336544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. J1-31 protein expression in astrocytes and astrocytomas.
    Shuangshoti S; Thorner PS; Ruangvejvorachai P; Saha B; Groshen S; Taylor CR; Malhotra S; Imam SA
    Neuropathology; 2009 Oct; 29(5):521-7. PubMed ID: 19019178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ethnicity delineates different genetic pathways in malignant glioma.
    Chen P; Aldape K; Wiencke JK; Kelsey KT; Miike R; Davis RL; Liu J; Kesler-Diaz A; Takahashi M; Wrensch M
    Cancer Res; 2001 May; 61(10):3949-54. PubMed ID: 11358811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant p53 expression in astrocytic neoplasms of the brain: association with proliferation.
    Haapasalo H; Isola J; Sallinen P; Kalimo H; Helin H; Rantala I
    Am J Pathol; 1993 May; 142(5):1347-51. PubMed ID: 7684193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proliferation and programmed cell death: role of p53 protein in high and low grade astrocytoma.
    Facoetti A; Ranza E; Nano R
    Anticancer Res; 2008; 28(1A):15-9. PubMed ID: 18383819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Axin induces cell death and reduces cell proliferation in astrocytoma by activating the p53 pathway.
    Zhang LY; Ye J; Zhang F; Li FF; Li H; Gu Y; Liu F; Chen GS; Li Q
    Int J Oncol; 2009 Jul; 35(1):25-32. PubMed ID: 19513548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Manganese superoxide dismutase (MnSOD) is a malignant astrocytoma specific biomarker and associated with adverse prognosis in p53 expressing glioblastoma.
    Shwetha SD; Shastry AH; Arivazhagan A; Santosh V
    Pathol Res Pract; 2016 Jan; 212(1):17-23. PubMed ID: 26616112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study on the expression of epidermal growth factor receptor and p53 in astrocytic gliomas: evidence for a distinct genetic pathway].
    Dong L; Pu PY; Wang H; Wang GX; Kang CS; Jiao DR
    Zhonghua Bing Li Xue Za Zhi; 2006 Apr; 35(4):232-6. PubMed ID: 16776982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High frequency of p53 protein accumulation without p53 gene mutation in human juvenile pilocytic, low grade and anaplastic astrocytomas.
    Lang FF; Miller DC; Pisharody S; Koslow M; Newcomb EW
    Oncogene; 1994 Mar; 9(3):949-54. PubMed ID: 8108140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous alterations of retinoblastoma and p53 protein expression in astrocytic tumors.
    Rathore A; Kamarajan P; Mathur M; Sinha S; Sarkar C
    Pathol Oncol Res; 1999; 5(1):21-7. PubMed ID: 10079373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53 expression and subcellular survivin localization improve the diagnosis and prognosis of patients with diffuse astrocytic tumors.
    Faccion RS; Bernardo PS; de Lopes GPF; Bastos LS; Teixeira CL; de Oliveira JA; Fernandes PV; Dubois LG; Chimelli L; Maia RC
    Cell Oncol (Dordr); 2018 Apr; 41(2):141-157. PubMed ID: 29374392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 protein alterations in adult astrocytic tumors and oligodendrogliomas.
    Nayak A; Ralte AM; Sharma MC; Singh VP; Mahapatra AK; Mehta VS; Sarkar C
    Neurol India; 2004 Jun; 52(2):228-32. PubMed ID: 15269478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathologic significance of proliferative activity and oncoprotein expression in astrocytic tumors.
    Bian XW; Shi JQ; Liu FX
    Anal Quant Cytol Histol; 2000 Dec; 22(6):429-37. PubMed ID: 11147296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic indicators in a range of astrocytic tumours: an immunohistochemical study with Ki-67 and p53 antibodies.
    Ellison DW; Steart PV; Bateman AC; Pickering RM; Palmer JD; Weller RO
    J Neurol Neurosurg Psychiatry; 1995 Oct; 59(4):413-9. PubMed ID: 7561922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [An immunohistochemical study of the expression of the oncoprotein p53 in astrocytic gliomas of the cerebral hemispheres].
    Korshunov AG; Sycheva RV
    Arkh Patol; 1996; 58(6):37-42. PubMed ID: 9139592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.